SCHEMBL21744741

SCHEMBL21744741

CC(C)(C)OC(=O)NCCCCNCc1ccc(C(F)(F)F)cn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.44
MAOB P27338 1/20 0.44
CYP3A4 P08684 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
CA12 O43570 4/20 0.42
CA1 P00915 4/20 0.42
CA2 P00918 4/20 0.42
CA9 Q16790 4/20 0.42
TLR7 Q9NYK1 3/20 0.42
IL6 P05231 2/20 0.42
STK17B O94768 1/20 0.42
STK17A Q9UEE5 1/20 0.42
GAA P10253 2/20 0.40
POLB P06746 1/20 0.40
CACNA1H O95180 1/20 0.39
CACNA1B Q00975 1/20 0.39
CACNA1C Q13936 1/20 0.39
MIF P14174 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30069409 1.00 MAOA (0.44) MAOAMAOBCYP3A4TDP1CA12
SCHEMBL21744203 0.86 MAOA (0.46) MAOAMAOBCYP3A4TDP1CA12
SCHEMBL30069427 0.86 MAOA (0.46) MAOAMAOBCYP3A4TDP1CA12
SCHEMBL21744310 0.85 MAOA (0.47) MAOAMAOBCYP3A4TDP1CA12
SCHEMBL30069413 0.85 MAOA (0.47) MAOAMAOBCYP3A4TDP1CA12
SCHEMBL21743816 0.84 STK17B (0.48) MAOAMAOBCYP3A4TDP1CA12
SCHEMBL30069433 0.84 STK17B (0.48) MAOAMAOBCYP3A4TDP1CA12
SCHEMBL30069403 0.83 CA12 (0.48) MAOAMAOBCYP3A4TDP1CA12
SCHEMBL21744742 0.83 CA12 (0.48) MAOAMAOBCYP3A4TDP1CA12
SCHEMBL31019539 0.82 POLB (0.46) MAOAMAOBGAAPOLBCACNA1H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230112832-A1 Chemokine CXCR4 Receptor Modulators and Uses Related Thereto UNIV EMORY (US) 2023-04-13 US disclosed
US-20200054623-A1 Chemokine CXCR4 Receptor Modulators and Uses Related Thereto EMORY UNIVERSITY 2020-02-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200054623-A1 Chemokine CXCR4 Receptor Modulators and Uses Related Thereto CXCR4, CXCL12, CXCR1 MAOA 4180/4885MAOB 4428/4885CYP3A4 4527/4885
US-20230112832-A1 Chemokine CXCR4 Receptor Modulators and Uses Related Thereto CXCR4, CXCL12, CXCR1 MAOA 4180/4885MAOB 4428/4885CYP3A4 4527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.